Although prior knowledge of STK32A is limited, it has been linked to stomach adenocarcinoma (STAD) where its overexpression is associated with lower overall survival (Southekal et al., 2021), and somatic mutations in Stk32a have also been identified in neuroendocrine carcinoma of the lung and metastatic melanoma (Greenman et al., 2007). This evidence concerns the gene STK32A and metastatic melanoma.